Drugs / Norepinephrine
last change 3 days ago re-read 2 minutes ago

Norepinephrine

Other / unclassified

Developed for
hypotensive disorder · infectious disease with sepsis · hypertensive disorder · arterial disorder · orthostatic hypotension 2 · radiodermatitis · acute kidney injury · cardiogenic shock
+20 more · heart failure · ischemic stroke · pulmonary arterial hypertension · acidosis disorder · acute respiratory distress syndrome · alopecia · brain ischemia · chronic obstructive pulmonary disease · chronic thromboembolic pulmonary hypertension · essential hypertension · liver failure · acute myocardial infarction · brain injury · heart disorder · hepatorenal syndrome · neonatal respiratory failure · orthostatic hypotension · postoperative ventricular dysfunction · pulmonary hypertension · pulmonary hypertension, neonatal
Investigated by
General Hospital of Ningxia Medical University · Cairo University · Mansoura University · ProCertus BioPharm, Inc · Tanta University · University of Missouri-Columbia
+98 more · Beijing Tiantan Hospital · Centre Hospitalier Universitaire, Amiens · H. Lee Moffitt Cancer Center and Research Institute · National Heart, Lung, and Blood Institute (NHLBI) · National Institutes of Health (NIH) · RenJi Hospital · Second Affiliated Hospital, School of Medicine, Zhejiang University · The Second Affiliated Hospital of Dalian Medical University · Universitas Sumatera Utara · University of Alberta · Yonsei University · Air Force Military Medical University, China · American Heart Association · Assistance Publique - Hôpitaux de Paris · Assiut University · Bach Mai Hospital · Beijing Anzhen Hospital · Brigham and Women's Hospital · Brugmann University Hospital · Canadian Critical Care Trials Group · Canadian Institutes of Health Research (CIHR) · Central Hospital, Nancy, France · Centre Hospitalier Régional d'Orléans · Children's Hospital of Fudan University · China International Neuroscience Institution · China National Center for Cardiovascular Diseases · Chonnam National University Hospital · Dalian Municipal Central Hospital · Dow University of Health Sciences · Federal University of São Paulo · First Affiliated Hospital of Kunming Medical University · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Fonds de la Recherche en Santé du Québec · Francois Lamontagne · Fudan University · Guangdong Provincial People's Hospital · Hassan II University · HatYai Hospital · Herlev Hospital · Hospital dos Servidores do Estado do Rio de Janeiro · Indonesia University · Institute of Liver and Biliary Sciences, India · Jeju National University Hospital · Jennifer Cutler · Kalasin Hospital · Kasr El Aini Hospital · Khon Kaen Hospital · Koç University · London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's · Maharaj Nakorn Si Thammarat · Massachusetts General Hospital · Mayo Clinic · Medical University of Vienna · Mongi Slim Hospital · National Cancer Institute, Egypt · Netherlands Organisation for Scientific Research · Ningbo No. 1 Hospital · Oxford University Hospitals NHS Trust · Peking Union Medical College Hospital · Peking University First Hospital · Polymun Scientific, Vienna, Austria · Pontificia Universidad Catolica de Chile · Radboud University Medical Center · Renmin Hospital of Wuhan University · Rennes University Hospital · Russell Richardson · Samuel Lunenfeld Research Institute, Mount Sinai Hospital · Seoul National University Hospital · Sepsis Occurrence in Acutely Ill Patients · Shanghai Zhongshan Hospital · Siriraj Hospital · Sohag University · Southeast University, China · Suez Canal University · all 104 on the full record

Trials 116 · started per year

today
1
1
1
1
1
1
3
1
1
2
1
2
3
1
5
7
7
11
7
4
9
12
15
10
9
199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025202620272028
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 05 trials
Phase 0 NCT06520982 Sep 2024 → Jun 2027 expected sympathetic nervous system disorder University of Missouri-Columbia Recruiting No outcome recorded
Phase 0 NCT05219799 Mar 2023 → Jun 2026 overdue isoproterenol-mediated vasodilatation, obesity disorder University of Missouri-Columbia Recruiting No outcome recorded
Phase 0 NCT04436731 Dec 2020 → Jun 2026 overdue obesity disorder University of Missouri-Columbia Active not recruiting No outcome recorded
Phase 0 NCT04218773 Sep 2020 → Aug 2026 hypertensive disorder, ischemic stroke Yale University Suspended No outcome recorded
Phase 0 NCT02759510 Jun 2016 heart failure RenJi Hospital Unknown No outcome recorded
Phase 16 trials
Phase 1 NCT03684213 Oct 2018 → May 2024 cardiovascular disorder The University of Texas at Arlington Completed No outcome recorded
Phase 1 NCT01367990 Jul 2011 → Feb 2012 alopecia, radiodermatitis ProCertus BioPharm, Inc Terminated No outcome recorded
Phase 1 NCT01263366 Jan 2011 → Apr 2013 radiodermatitis ProCertus BioPharm, Inc Terminated No outcome recorded
Phase 1 NCT01426529 Oct 2010 → Oct 2026 expected hypertensive disorder Brigham and Women's Hospital Active not recruiting No outcome recorded
Phase 1 NCT02966665 Sep 2008 → Aug 2026 overdue chronic obstructive pulmonary disease, heart failure, pulmonary arterial hypertension Russell Richardson Recruiting No outcome recorded
Phase 1 NCT00264186 Jun 2005 → ? Medical University of Vienna Completed No outcome recorded
Phase 1/22 trials
Phase 1/2 NCT03773276 Dec 2018 → Apr 2020 Mansoura University Completed No outcome recorded
Phase 1/2 NCT01544504 Mar → May 2012 radiodermatitis ProCertus BioPharm, Inc Withdrawn No outcome recorded
Phase 22 trials
Phase 2 NCT03702400 Oct 2018 → Jun 2020 hypotensive disorder Hospital dos Servidores do Estado do Rio de Janeiro Completed No outcome recorded
Phase 2 NCT00134212 Mar 2002 → Jun 2004 infectious disease with sepsis Rennes University Hospital Completed No outcome recorded
Phase 2/33 trials
Phase 2/3 NCT06461390 Mar → May 2024 infectious disease with sepsis Indonesia University Completed No outcome recorded
Phase 2/3 NCT03833895 Feb → Sep 2019 China International Neuroscience Institution Completed No outcome recorded
Phase 2/3 NCT00148278 Oct 1999 → Dec 2004 infectious disease with sepsis University of Versailles Completed No outcome recorded
Phase 314 trials
Phase 3 NCT06059144 Nov 2024 → Aug 2027 expected ischemic stroke University Hospital, Bordeaux Recruiting No outcome recorded
Phase 3 NCT05497700 Sep 2022 → Sep 2023 orthostatic hypotension 2 Brugmann University Hospital Unknown No outcome recorded
Phase 3 NCT05521152 Aug 2022 → Jul 2024 biliary atresia Kasr El Aini Hospital Completed No outcome recorded
Phase 3 NCT05355974 Aug 2022 → Jul 2024 hypotensive disorder, orthostatic hypotension 2, respiratory failure Wright State University Completed No outcome recorded
Phase 3 NCT05276596 Nov 2021 → Dec 2024 hypotensive disorder Centre Hospitalier Universitaire, Amiens Completed No outcome recorded
Phase 3 NCT04536194 Oct 2020 → Aug 2021 congenital heart disease, infant botulism Children's Hospital of Fudan University Completed No outcome recorded
Phase 3 NCT04789005 Nov 2019 → May 2020 Tribhuvan University Teaching Hospital, Institute Of Medicine. Completed No outcome recorded
Phase 3 NCT04067817 Oct → Dec 2019 hypotensive disorder The Second Affiliated Hospital of Dalian Medical University Unknown No outcome recorded
Phase 3 NCT03434028 Mar 2018 → May 2022 infectious disease with sepsis Massachusetts General Hospital Completed No outcome recorded
Phase 3 NCT03340779 Jan 2018 → Nov 2019 cardiogenic shock Central Hospital, Nancy, France Unknown No outcome recorded
Phase 432 trials
Phase 4 NCT07633600 Jun 2026 → Jun 2027 expected Jennifer Cutler Not yet recruiting No outcome recorded
Phase 4 NCT07662408 May 2026 → Mar 2027 expected Sohag University Recruiting No outcome recorded
Phase 4 NCT07529795 Apr → Sep 2026 expected hypotensive disorder, peritonitis Bach Mai Hospital Not yet recruiting No outcome recorded
Phase 4 NCT07322419 Jan → Dec 2026 expected Mansoura University Recruiting No outcome recorded
Phase 4 NCT06921473 Sep → Dec 2025 acidosis disorder mehmet özkılıç Completed No outcome recorded
Phase 4 NCT06574555 Apr → Aug 2025 cardiac rhythm disease, hypertensive disorder, hypotensive disorder Pontificia Universidad Catolica de Chile Completed No outcome recorded
Phase 4 NCT06248593 Jan 2025 → Mar 2026 overdue hypotensive disorder Hassan II University Recruiting No outcome recorded
Phase 4 NCT06498115 Jul → Sep 2024 overdue The Third People's Hospital of Bengbu Recruiting No outcome recorded
Phase 4 NCT07327320 Jun 2024 → Oct 2025 hypotensive disorder Tam Anh Research Institute Completed No outcome recorded
Phase 4 NCT06334549 Mar 2024 → Dec 2025 overdue hypotensive disorder Dalian Municipal Central Hospital Recruiting No outcome recorded
Phase not applicable52 trials
NCT07627360 Jul → Oct 2026 expected Suez Canal University Not yet recruiting No outcome recorded
NCT07667829 Jun 2026 → Dec 2028 expected chronic thromboembolic pulmonary hypertension, pulmonary arterial hypertension China National Center for Cardiovascular Diseases Not yet recruiting No outcome recorded
NCT07562932 May 2026 → May 2031 expected cardiogenic shock Chonnam National University Hospital Not yet recruiting No outcome recorded
NCT07418541 Apr → Dec 2026 expected acute kidney injury, infectious disease with sepsis Universitas Sumatera Utara Not yet recruiting No outcome recorded
NCT07343206 Jan 2026 → Jan 2028 expected infectious disease with sepsis Siriraj Hospital Recruiting No outcome recorded
NCT06508359 Aug 2025 → Apr 2026 General Hospital of Ningxia Medical University Completed No outcome recorded
NCT06158035 Jul → Dec 2025 General Hospital of Ningxia Medical University Unknown No outcome recorded
NCT06158009 Apr → Jun 2025 General Hospital of Ningxia Medical University Unknown No outcome recorded
NCT07153601 Feb → May 2025 hypotensive disorder, pregnancy disorder Universitas Sumatera Utara Completed No outcome recorded
NCT06158048 Jan → Apr 2025 General Hospital of Ningxia Medical University Completed No outcome recorded
Also used as a comparator or background therapy in 111 trials
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 02 trials
Phase 0 NCT06053398 Comparator Nov 2023 → Dec 2024 hypotensive disorder University of Texas Southwestern Medical Center Completed No outcome recorded
Phase 0 NCT02789150 Comparator Jan 2015 → Jan 2018 hepatorenal syndrome University of Louisville Completed No outcome recorded
Phase 1/23 trials
Phase 1/2 NCT06977659 Comparator May 2025 → Jul 2027 expected Visarat Palitnonkiat Enrolling by invitation No outcome recorded
Phase 1/2 NCT07296029 Background Jul 2022 → Feb 2025 critical illness polyneuropathy, delirium, respiratory failure Queen's University Completed No outcome recorded
Phase 1/2 NCT01285908 Comparator Jan 2011 → Sep 2012 orthostatic hypotension National Institute of Neurological Disorders and Stroke (NINDS) Completed No outcome recorded
Phase 28 trials
Phase 2 NCT07614438 Comparator Aug 2026 overdue chronic thromboembolic pulmonary hypertension Fondation Hôpital Saint-Joseph Not yet recruiting No outcome recorded
Phase 2 NCT06302998 Comparator Jun 2024 → Dec 2025 infectious disease with sepsis Mansoura University Unknown No outcome recorded
Phase 2 NCT04339868 Comparator Apr 2020 → Mar 2025 infectious disease with sepsis Mahidol University Unknown No outcome recorded
Phase 2 NCT03015857 Comparator Jan → Mar 2017 Kasr El Aini Hospital Completed No outcome recorded
Phase 2 NCT02019810 Comparator Oct 2014 → Jun 2016 brain injury University Hospital, Grenoble Unknown No outcome recorded
Phase 2/34 trials
Phase 2/3 NCT03483753 Comparator Jan 2019 → Oct 2023 University of Sao Paulo Withdrawn No outcome recorded
Phase 2/3 NCT03107858 Comparator Nov 2017 → Jan 2019 Assiut University Unknown No outcome recorded
Phase 2/3 NCT02428062 Background Oct 2014 → Dec 2018 Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico Suspended No outcome recorded
Phase 2/3 NCT00628160 Comparator Oct 2006 → Dec 2012 cirrhosis of liver, infectious disease with sepsis Hospital Clinic of Barcelona Completed No outcome recorded
Phase 313 trials
Phase 3 NCT06344442 Comparator Apr → May 2025 overdue acute kidney injury Assistance Publique - Hôpitaux de Paris Recruiting No outcome recorded
Phase 3 NCT06464510 Comparator Nov 2024 → Aug 2027 expected infectious disease with sepsis Hospital do Coracao Recruiting No outcome recorded
Phase 3 NCT04742764 Background Jan 2024 → Oct 2026 infectious disease with sepsis University of Pecs Suspended No outcome recorded
Phase 3 NCT05568160 Comparator Jan 2023 → Mar 2026 overdue Centre Hospitalier Universitaire Dijon Active not recruiting No outcome recorded
Phase 3 NCT05179499 Comparator Oct 2022 → Nov 2026 expected infectious disease with sepsis NHS Greater Glasgow and Clyde Recruiting No outcome recorded
Phase 437 trials
Phase 4 NCT06746753 Comparator Jul 2026 → Sep 2028 expected infectious disease with sepsis Wake Forest University Health Sciences Not yet recruiting No outcome recorded
Phase 4 NCT07322133 Comparator Jun 2026 → Jun 2027 expected hypotensive disorder, neonatal respiratory failure, pulmonary hypertension, neonatal University of California, Davis Recruiting No outcome recorded
Phase 4 NCT07379710 Comparator Jun → Dec 2026 expected Cairo University Not yet recruiting No outcome recorded
Phase 4 NCT06802224 Comparator Apr 2025 → Jul 2028 expected acute kidney injury, acute myocardial infarction University of California, San Francisco Recruiting No outcome recorded
Phase 4 NCT07259655 Comparator Mar → May 2025 hypotensive disorder Hopital Charles Nicolle Terminated No outcome recorded
Phase not applicable44 trials
NCT07706426 Comparator Jul 2026 → Jan 2027 expected hypotensive disorder Ain Shams University Not yet recruiting No outcome recorded
NCT07077265 Comparator Aug → Dec 2025 Kasr El Aini Hospital Completed No outcome recorded
NCT06930235 Comparator Mar → Oct 2025 Sohag University Completed No outcome recorded
NCT06631482 Comparator Sep 2024 → Oct 2025 overdue orthostatic hypotension 2 National Taiwan University Hospital Active not recruiting No outcome recorded
NCT06498076 Comparator Aug 2024 → Jan 2025 Hopital Charles Nicolle Completed No outcome recorded

Evidence & citations 12 cited values

Every value below carries the sentence it was read from. 228 sources stand behind the page.

FieldValueCited text
Known as norepinephrine Norepinephrine will be used as preferred vasopressor and titrated to achieve mean arterial pressure (MAP) between 65 mmHg and 75 mmHg. "Rescue fluids" may be administered as...” NCT03434028
227

“Blood pressure is raised or lowered via norepinephrine (dose range 1-10 mcg/min) and labetalol (dose range 0-2 mg/min), respectively, to match the researched blood pressure targets.” NCT07296029

“10 ml/kg 6% Hydroxyethyl starch (130/0.4) coload combined with an initial infusion dose of prophylactic norepinephrine (0.025 ug/kg/min) simultaneous with spinal anesthesia.” NCT05475990

“If hypotension was present it was treated with vasopressor as 10 mcg bolus or continuous infusion of norepinephrine (Arterenol® Sanofi, Germany).” NCT02337010

“The main outcomes of the study are in-hospital mortality, norepinephrine equivalent dose, ICU scores, and inflammatory markers.” NCT06302998

Norepinephrine as a vasopressor and dobutamine - if needed - as an inotrope will be administered by the attending physician.” NCT04742764

“Protocolized treatment with fluid administration, norepinephrine, and dobutamine to prevent intraoperative hypotension.” NCT06631482

“An initial infusion dose of prophylactic norepinephrine (0.025 ug/kg/min) simultaneous with spinal anesthesia.” NCT05712018

“An initial infusion dose of prophylactic norepinephrine (0.05 ug/kg/min) simultaneous with spinal anesthesia.” NCT06151457

“An initial infusion dose of prophylactic norepinephrine (0.05 ug/kg/min) simultaneous with spinal anesthesia.” NCT06151509

Norepinephrine will be initiated @0.05mcg/kg/min and titrated upto 0.5 mcg/kg/min to maintain a MAP” NCT06556472

norepinephrine infusion doses ( 0.025, 0.05, and 0.075, 0.1 mic/kg/min) post spinal anesthesia .” NCT07706426

“If MAP does not increase norepinephrine will be titrated to reach the MAP target (85 mmHg).” NCT06125184

“Dopamine (1-20 µg/Kg/min) and/or norepinephrine (0.05-4 µg/Kg/min) until shock resolution” NCT00628160

Norepinephrine was recommended as the first vasopressor for septic shock resuscitation.” NCT04339868

Norepinephrine will be administered intravenously at a rate of 0.06 µg/kg/min” NCT06367205

“will receive noradrenaline (norepinephrine) a bolus of 0,25 mcg/kg once” NCT03421860

“Vasopressors such as Norepinephrine, dopamine, milrinone, dobutamine” NCT02730117

“Vasopressors such as Norepinephrine, dopamine, milrinone, dobutamine” NCT04792424

Norepinephrine, dopamine, epinephrine” NCT03020407

“phenylephrine, norepinephrineNCT02414555

NorepinephrineNCT07633600

NorepinephrineNCT03629418

norepinephrineNCT01800877

NorepinephrineNCT05658692

NCT05637164

NCT05568160

NCT05035888

NCT07614438

NCT01426529

NCT06158009

NCT04067817

NCT05193968

NCT05133817

NCT03455322

NCT00197886

NCT05564741

NCT05035498

NCT05355974

NCT01285908

NCT05035485

NCT02118467

NCT02203630

NCT05035472

NCT06802224

NCT04214145

NCT07662408

NCT05318066

NCT02789150

NCT06934798

NCT06028256

NCT06574555

NCT06311903

NCT03288051

NCT02428062

NCT05368415

NCT07529795

NCT07627360

NCT02479529

NCT03706755

NCT03626454

NCT03780686

NCT02477501

NCT01945983

NCT04592744

NCT03997500

NCT06158022

NCT06158035

NCT06520982

NCT05886192

NCT03806582

NCT07418541

NCT02241083

NCT03182088

NCT02019810

NCT06234592

NCT06461390

NCT03106831

NCT06158048

NCT06746753

NCT07327320

NCT03773276

NCT02306239

NCT02472249

NCT04556370

NCT03070665

NCT07706426

NCT04683614

NCT01718613

NCT03684213

NCT07667829

NCT04934748

NCT04195321

NCT07053163

NCT04556357

NCT03864094

NCT06053398

NCT06921473

NCT05774067

NCT02966665

NCT04272567

NCT02854787

NCT06462313

NCT02412189

NCT05665881

NCT03163407

NCT04789005

NCT06102382

NCT06836986

NCT02962986

NCT06711432

NCT05414877

NCT06498115

NCT01568853

NCT03702400

NCT03965117

NCT05637606

NCT03849508

NCT05970770

NCT04436731

NCT03483753

NCT05997732

NCT07322419

NCT01493102

NCT04789330

NCT07322133

NCT03234816

NCT06512402

NCT06512415

NCT04170751

NCT02969239

NCT04951167

NCT07343206

NCT07379710

NCT05049278

NCT05264870

NCT05290740

NCT03833895

NCT00639015

NCT07153601

NCT04053478

NCT07259655

NCT03248791

NCT01697410

NCT06498076

NCT02832596

NCT00624650

NCT05525416

NCT04367103

NCT02726620

NCT02354833

NCT02654847

NCT00264186

NCT03302650

NCT05492968

NCT04777383

NCT06157320

NCT05179499

NCT00148278

NCT07562932

NCT02542748

NCT06334549

NCT03719625

NCT03872570

NCT00894621

NCT01609491

NCT00294606

NCT06285396

NCT01544504

NCT04312971

NCT00848770

NCT06464510

NCT02519699

NCT05814601

NCT04302584

NCT04218773

NCT06080178

NCT03163914

NCT03107858

NCT07077265

NCT06496061

NCT05836272

NCT04991662

NCT05497700

NCT06059144

NCT03308708

NCT03328533

NCT06344442

NCT01271114

NCT02085291

NCT03215797

NCT00134212

NCT01060930

NCT04536194

NCT00604019

NCT05248932

NCT06163352

NCT02759510

NCT00481572

NCT03792906

NCT01418118

NCT06248593

NCT02675868

NCT01505231

NCT04295993

NCT06977659

NCT02473263

NCT01263366

NCT06213935

NCT07330908

NCT02455115

NCT03712111

NCT00314704

NCT06930235

NCT03015857

NCT05219799

NCT01367743

NCT01367990

NCT00841633

NCT04501861

NCT05276596

NCT02454348

NCT05521152

NCT02640846

NCT00549419

NCT04522297

NCT06508359

NCT03340779

Known as Arterenol “15 mg of Norepinephrine (Arterenol; Sanofi-Aventis, Frankfurt, Germany) in 250 ml D5W infused at the rate of 10 ml/h for 10 mcg/min using infusion pump.” NCT04302584
1

“If hypotension was present it was treated with vasopressor as 10 mcg bolus or continuous infusion of norepinephrine (Arterenol® Sanofi, Germany).” NCT02337010

Known as Levophed “Norepinephrine (Levophed)” NCT02789150
Known as LEVOPHEDR “Norepinephrine bitartrate (LEVOPHEDR, Pfizer inc.) 4 mg/4ml + 5% Dextrose in water 246 ml (total volume 250 ml, final concentration 16 mcg/ml) infuses intravenously via a...” NCT06977659
Known as NOR “Esmolol, Sodium Nitroprussiate (NPS) or Norepinephrine (NOR)” NCT00848770
Known as noradrenaline “We compared the effects of dopexamine and norepinephrine (noradrenaline) with those of epinephrine (adrenaline) on gastric mucosal blood flow (GMBF) in patients with septic shock.” PMID 16507156 Feb 2006
1

“will receive noradrenaline (norepinephrine) a bolus of 0,25 mcg/kg once” NCT03421860

Known as Norepienphrine “Continuous infusion of Norepienphrine 20 μg/mL (=NE 4mg” NCT04214145
Known as Norepinephrine Bitartrate Norepinephrine bitartrate (LEVOPHEDR, Pfizer inc.) 4 mg/4ml + 5% Dextrose in water 246 ml (total volume 250 ml, final concentration 16 mcg/ml) infuses intravenously via a...” NCT06977659
4

“Drug: Norepinephrine BitartrateNCT05836272

“Drug: Norepinephrine BitartrateNCT05521152

“Drug: Norepinephrine BitartrateNCT05997732

“Drug: norepinephrine bitartrateNCT05637164

Known as Norepinephrine Hydrochloride “Drug: Norepinephrine HydrochlorideNCT06028256
Action Activate “Norepinephrine acts not only as an α adrenoceptor receptor agonist, but also as a weaker β adrenergic receptor agonist.” NCT02759510
Modality Other / unclassified “In septic shock, when volume resuscitation fails to restore mean arterial pressure, catecholamines such as dopamine, dobutamine, epinephrine, or norepinephrine are used, either...” NCT00134212
Route Intravenous “Norepinephrine is administered through the central venous catheter.” NCT00841633